US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Contineum Therapeutics, INC.

14.06

-0.3100-2.16%

Post-market: 14.060.00000.00%19:34 EDT

Volume:122.84K

Turnover:1.73M

Market Cap:524.94M

PE:-7.35

High:14.45

Open:14.45

Low:13.78

Close:14.37

52wk High:16.91

52wk Low:5.07

Shares:37.34M

Float Shares:27.59M

Volume Ratio:0.67

T/O Rate:0.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9138

EPS(LYR):-2.1700

ROE:-26.88%

ROA:-18.18%

PB:2.10

PE(LYR):-6.48

Loading ...

Overview Company News Filings

Companies Like Contineum Therapeutics (NASDAQ:CTNM) Are In A Position To Invest In Growth

Simply Wall St.

Contineum Therapeutics Updates Strategy, Highlights PIPE-791 Leadership

Contineum Therapeutics CSO Daniel S. Lorrain Disposes of USD 16,640 in Common Shares

Contineum Therapeutics CEO Carmine N. Stengone Disposes of 2,500 Shares for $40,000

Contineum Therapeutics CSO Daniel S. Lorrain Disposes of USD 556,791 Common Shares

Contineum Therapeutics CEO Carmine Stengone Sells 10,000 Common Shares for $160,080

Contineum publishes manuscript on PIPE-791 in Journal of Medicinal Chemistry

Contineum Launches Global Phase 2 Trial of Pipe-791 in Idiopathic Pulmonary Fibrosis Patients

Contineum Stockholders Hold 2026 Virtual Annual Meeting

Contineum Therapeutics Shareholders Elect Class II Directors at Annual Meeting

Contineum Therapeutics CSO Daniel S. Lorrain disposes of 4,170 common shares for $54,866.19

Contineum Therapeutics to present at Goldman Sachs Global Healthcare Conference

Contineum Therapeutics grants 51,000-share inducement stock option to new employee

Contineum Therapeutics Is Maintained at Equal-Weight by Morgan Stanley

Contineum price target raised to $16 from $14 at Morgan Stanley

Morgan Stanley Raises Price Target on Contineum Therapeutics to $16 From $14, Keeps Equalweight Rating

MT Newswires Live

Contineum Therapeutics to present at RBC Capital Markets Global Healthcare Conference

Contineum presents PIPE-791 pulmonary fibrosis data at ATS 2026 conference

Stifel Nicolaus Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM)

Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTNM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":14.06,"timestamp":1784923200000,"preClose":14.37,"halted":0,"volume":122843,"hourTrading":{"tag":"盘后","latestPrice":14.06,"preClose":14.06,"latestTime":"19:34 EDT","volume":4226,"amount":59417.56,"timestamp":1784936046149,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.021572720946416057,"floatShares":27590800,"shares":37336000,"eps":-1.91379,"marketStatus":"Market Closed","change":-0.31,"latestTime":"07-24 16:00:00 EDT","open":14.45,"high":14.45,"low":13.78,"amount":1733689.278307,"amplitude":0.046625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.91379,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":14.37,"postHourTrading":{"tag":"盘后","latestPrice":14.06,"preClose":14.06,"latestTime":"19:34 EDT","volume":4226,"amount":59417.56,"timestamp":1784936046149,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6738293573799882,"impliedVol":1.2994,"impliedVolPercentile":0.6494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","floatShares":27590800,"roa":"-18.18%","roe":"-26.88%","lyrEps":-2.169999,"volumeRatio":0.6738293573799882,"shares":37336000,"dividePrice":0,"high":14.45,"amplitude":0.046625,"preClose":14.37,"low":13.78,"week52Low":5.07,"pbRate":"2.10","week52High":16.91,"institutionHeld":0,"latestPrice":14.06,"eps":-1.91379,"divideRate":0,"volume":122843,"delay":0,"ttmEps":-1.91379,"open":14.45,"prevYearClose":11.43,"prevWeekClose":14.23,"prevMonthClose":16.39,"prevQuarterClose":16.39,"fiveDayClose":14.23,"twentyDayClose":13.36,"sixtyDayClose":12.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-05","symbol":"CTNM","fiscalQuarterEnding":"2026/03","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2026-03-05","symbol":"CTNM","fiscalQuarterEnding":"2025/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-10-30","symbol":"CTNM","fiscalQuarterEnding":"2025/09","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-08-05","symbol":"CTNM","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2025-05-14","symbol":"CTNM","fiscalQuarterEnding":"2025/03","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.2857,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1767931200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTNM","date":"2026-07-24","current":-7.346679,"percent":0.24552,"low":-16.425726,"twenty":-9.67595,"median":-5.858705,"eighty":-2.342386,"high":28.322904,"avg":-3.748341,"sd":10.125998,"marketCap":537242237},"quantilePoints":[{"date":"2024-04-05","current":16.281367,"twenty":16.281367,"median":16.281367,"eighty":16.281367,"marketCap":369912656},{"date":"2024-04-12","current":17.609251,"twenty":16.281367,"median":16.569509,"eighty":16.868158,"marketCap":400082176},{"date":"2024-04-19","current":17.122563,"twenty":16.281367,"median":16.868158,"eighty":17.144685,"marketCap":389024629},{"date":"2024-04-26","current":17.686678,"twenty":16.315104,"median":17.089379,"eighty":17.59819,"marketCap":401841332},{"date":"2024-05-03","current":16.48102,"twenty":16.48102,"median":17.122563,"eighty":17.59819,"marketCap":374448771},{"date":"2024-05-10","current":17.719862,"twenty":16.38147,"median":17.105971,"eighty":17.59819,"marketCap":402595255},{"date":"2024-05-17","current":16.547386,"twenty":16.392531,"median":17.100441,"eighty":17.487579,"marketCap":375956618},{"date":"2024-05-24","current":17.819411,"twenty":16.48102,"median":17.133624,"eighty":17.59819,"marketCap":404857026},{"date":"2024-05-31","current":20.173009,"twenty":16.534113,"median":17.172337,"eighty":17.68889,"marketCap":385849140},{"date":"2024-06-07","current":21.67926,"twenty":16.768608,"median":17.354846,"eighty":18.209439,"marketCap":414659209},{"date":"2024-06-14","current":22.311348,"twenty":16.85046,"median":17.388029,"eighty":20.619504,"marketCap":426749148},{"date":"2024-06-21","current":26.466988,"twenty":16.894704,"median":17.487579,"eighty":21.17897,"marketCap":506234071},{"date":"2024-06-28","current":25.216261,"twenty":16.921251,"median":17.542884,"eighty":21.517876,"marketCap":482311425},{"date":"2024-07-05","current":27.018383,"twenty":16.987617,"median":17.609251,"eighty":21.78147,"marketCap":516780614},{"date":"2024-07-12","current":28.242212,"twenty":17.042923,"median":17.692208,"eighty":22.916538,"marketCap":540188796},{"date":"2024-07-15","current":27.932893,"twenty":17.049559,"median":17.697739,"eighty":23.766494,"marketCap":534272442},{"date":"2024-08-02","current":26.224911,"twenty":17.056196,"median":17.697739,"eighty":24.100021,"marketCap":501603882},{"date":"2024-08-09","current":22.338245,"twenty":17.08938,"median":17.819411,"eighty":24.409341,"marketCap":427263614},{"date":"2024-08-16","current":-15.206885,"twenty":17.023013,"median":17.769636,"eighty":24.100021,"marketCap":478195700},{"date":"2024-08-23","current":-14.92058,"twenty":16.547386,"median":17.697739,"eighty":23.683112,"marketCap":469192554},{"date":"2024-08-30","current":-15.468649,"twenty":16.315104,"median":17.614781,"eighty":23.293101,"marketCap":486427149},{"date":"2024-09-06","current":-14.511573,"twenty":15.417858,"median":17.570537,"eighty":22.830467,"marketCap":456330916},{"date":"2024-09-13","current":-14.765157,"twenty":-14.025672,"median":17.410151,"eighty":22.682531,"marketCap":464305131},{"date":"2024-09-20","current":-16.425726,"twenty":-14.408503,"median":17.365907,"eighty":22.459283,"marketCap":516523382},{"date":"2024-09-27","current":-15.272326,"twenty":-14.745525,"median":17.19999,"eighty":22.405488,"marketCap":480253562},{"date":"2024-10-04","current":-14.421591,"twenty":-14.887859,"median":17.133624,"eighty":22.351694,"marketCap":453501355},{"date":"2024-10-11","current":-13.521775,"twenty":-14.788061,"median":17.100441,"eighty":22.316727,"marketCap":425205752},{"date":"2024-10-18","current":-13.480875,"twenty":-14.745525,"median":17.039604,"eighty":22.010098,"marketCap":423919588},{"date":"2024-10-25","current":-13.309092,"twenty":-14.662087,"median":16.868158,"eighty":21.934785,"marketCap":418517700},{"date":"2024-10-31","current":-14.004404,"twenty":-14.595828,"median":16.547386,"eighty":21.78147,"marketCap":440382485},{"date":"2024-11-08","current":-13.455721,"twenty":-14.532841,"median":16.387,"eighty":21.655052,"marketCap":477166769},{"date":"2024-11-15","current":-13.193473,"twenty":-14.477216,"median":16.281367,"eighty":21.566291,"marketCap":467866942},{"date":"2024-11-22","current":-10.423934,"twenty":-14.434679,"median":15.167037,"eighty":21.517876,"marketCap":369653551},{"date":"2024-11-29","current":-10.838275,"twenty":-14.411775,"median":-9.795154,"eighty":21.388769,"marketCap":384346893},{"date":"2024-12-06","current":-10.358512,"twenty":-14.347406,"median":-10.271282,"eighty":21.17897,"marketCap":367333550},{"date":"2024-12-13","current":-10.031401,"twenty":-14.270231,"median":-10.358512,"eighty":21.154762,"marketCap":355733543},{"date":"2024-12-20","current":-9.70429,"twenty":-14.217087,"median":-10.242206,"eighty":20.950342,"marketCap":344133536},{"date":"2024-12-27","current":-10.569317,"twenty":-14.14183,"median":-10.271282,"eighty":20.635643,"marketCap":374809110},{"date":"2025-01-03","current":-10.525702,"twenty":-14.135286,"median":-10.358512,"eighty":20.603366,"marketCap":373262442},{"date":"2025-01-10","current":-9.718828,"twenty":-14.073857,"median":-10.358512,"eighty":20.25908,"marketCap":344649092},{"date":"2025-01-17","current":-9.071876,"twenty":-14.047944,"median":-10.256744,"eighty":19.850241,"marketCap":321706856},{"date":"2025-01-24","current":-8.19958,"twenty":-14.045305,"median":-10.209494,"eighty":18.599466,"marketCap":290773505},{"date":"2025-01-31","current":-7.429052,"twenty":-14.035488,"median":-10.009594,"eighty":17.759682,"marketCap":263449044},{"date":"2025-02-07","current":-6.883867,"twenty":-14.024036,"median":-9.925999,"eighty":17.706588,"marketCap":244115699},{"date":"2025-02-14","current":-5.589962,"twenty":-14.010948,"median":-9.718828,"eighty":17.697739,"marketCap":198231228},{"date":"2025-02-21","current":-5.742614,"twenty":-13.988044,"median":-9.667944,"eighty":17.693315,"marketCap":203644564},{"date":"2025-02-28","current":-5.19016,"twenty":-13.940599,"median":-9.518928,"eighty":17.660132,"marketCap":184053442},{"date":"2025-03-07","current":-3.942751,"twenty":-13.847345,"median":-9.071876,"eighty":17.615888,"marketCap":166612775},{"date":"2025-03-14","current":-4.371311,"twenty":-13.716463,"median":-8.19958,"eighty":17.604827,"marketCap":184722859},{"date":"2025-03-21","current":-4.377433,"twenty":-13.63957,"median":-8.126889,"eighty":17.576068,"marketCap":184981575},{"date":"2025-03-28","current":-4.561102,"twenty":-13.619937,"median":-7.567165,"eighty":17.520762,"marketCap":192743040},{"date":"2025-04-04","current":-3.75296,"twenty":-13.617995,"median":-7.116479,"eighty":17.456608,"marketCap":158592595},{"date":"2025-04-11","current":-2.528503,"twenty":-13.600664,"median":-6.847522,"eighty":17.401302,"marketCap":106849497},{"date":"2025-04-17","current":-2.681561,"twenty":-13.574128,"median":-6.436815,"eighty":17.385817,"marketCap":113317384},{"date":"2025-04-25","current":-2.767272,"twenty":-13.55286,"median":-5.742614,"eighty":17.372544,"marketCap":116939401},{"date":"2025-05-02","current":-2.430547,"twenty":-13.541408,"median":-5.640845,"eighty":17.334936,"marketCap":102710049},{"date":"2025-05-09","current":-2.418302,"twenty":-13.513595,"median":-5.553616,"eighty":17.244235,"marketCap":102192618},{"date":"2025-05-16","current":-2.045592,"twenty":-13.477603,"median":-5.430041,"eighty":17.188929,"marketCap":101933903},{"date":"2025-05-23","current":-2.030017,"twenty":-13.462755,"median":-5.321004,"eighty":17.144685,"marketCap":101157756},{"date":"2025-05-30","current":-1.853493,"twenty":-13.455721,"median":-5.117468,"eighty":17.144685,"marketCap":92361429},{"date":"2025-06-06","current":-2.154621,"twenty":-13.448154,"median":-4.770625,"eighty":17.122563,"marketCap":107366928},{"date":"2025-06-13","current":-2.40383,"twenty":-13.399073,"median":-4.628447,"eighty":17.122563,"marketCap":119785271},{"date":"2025-06-20","current":-1.895028,"twenty":-13.379975,"median":-4.585591,"eighty":17.104865,"marketCap":94431153},{"date":"2025-06-27","current":-2.081935,"twenty":-13.328858,"median":-4.536848,"eighty":17.091592,"marketCap":103744911},{"date":"2025-07-03","current":-2.014441,"twenty":-13.312364,"median":-4.445597,"eighty":17.06947,"marketCap":100381610},{"date":"2025-07-11","current":-2.092319,"twenty":-13.309092,"median":-4.377433,"eighty":17.036286,"marketCap":104262342},{"date":"2025-07-18","current":-1.993674,"twenty":-13.304184,"median":-4.325394,"eighty":16.96992,"marketCap":99346748},{"date":"2025-07-25","current":-2.959359,"twenty":-13.281279,"median":-4.150909,"eighty":16.894704,"marketCap":147467829},{"date":"2025-08-01","current":-3.063196,"twenty":-13.22336,"median":-4.01928,"eighty":16.841612,"marketCap":152642139},{"date":"2025-08-08","current":-3.062072,"twenty":-13.164683,"median":-3.75296,"eighty":16.657997,"marketCap":174115524},{"date":"2025-08-15","current":-3.58032,"twenty":-12.764301,"median":-3.489183,"eighty":16.507566,"marketCap":203584157},{"date":"2025-08-22","current":-4.951297,"twenty":-12.507357,"median":-3.639499,"eighty":16.427927,"marketCap":281540625},{"date":"2025-08-29","current":-4.956228,"twenty":-11.906412,"median":-3.948873,"eighty":16.385894,"marketCap":281821044},{"date":"2025-09-05","current":-5.419796,"twenty":-11.370375,"median":-4.039068,"eighty":16.354924,"marketCap":308180426},{"date":"2025-09-12","current":-5.824184,"twenty":-11.101417,"median":-4.150909,"eighty":16.301609,"marketCap":331174779},{"date":"2025-09-19","current":-6.115147,"twenty":-10.938589,"median":-4.325394,"eighty":16.232919,"marketCap":347719498},{"date":"2025-09-26","current":-5.355685,"twenty":-10.838275,"median":-4.374303,"eighty":15.930178,"marketCap":304534979},{"date":"2025-10-03","current":-5.301438,"twenty":-10.774307,"median":-4.411924,"eighty":15.250644,"marketCap":301450371},{"date":"2025-10-10","current":-5.996789,"twenty":-10.666723,"median":-4.53049,"eighty":8.143309,"marketCap":340989443},{"date":"2025-10-17","current":-6.144737,"twenty":-10.617293,"median":-4.573346,"eighty":-1.787038,"marketCap":349402011},{"date":"2025-10-24","current":-5.483906,"twenty":-10.566409,"median":-4.58636,"eighty":-1.820784,"marketCap":311825872},{"date":"2025-10-31","current":-5.197875,"twenty":-10.55914,"median":-4.692731,"eighty":-1.833764,"marketCap":295561573},{"date":"2025-11-07","current":-5.410266,"twenty":-10.548963,"median":-4.832939,"eighty":-1.851935,"marketCap":321299446},{"date":"2025-11-14","current":-5.356212,"twenty":-10.534425,"median":-4.919242,"eighty":-1.870107,"marketCap":318089369},{"date":"2025-11-21","current":-6.004854,"twenty":-10.522794,"median":-4.956228,"eighty":-1.897105,"marketCap":356610284},{"date":"2025-11-28","current":-5.439749,"twenty":-10.511164,"median":-5.1056,"eighty":-1.907489,"marketCap":323050396},{"date":"2025-12-05","current":-5.395524,"twenty":-10.480633,"median":-5.127036,"eighty":-1.940717,"marketCap":320423970},{"date":"2025-12-12","current":-6.422541,"twenty":-10.474818,"median":-5.15474,"eighty":-1.961484,"marketCap":381415418},{"date":"2025-12-19","current":-5.596996,"twenty":-10.473364,"median":-5.194017,"eighty":-1.980175,"marketCap":332388800},{"date":"2025-12-26","current":-6.230896,"twenty":-10.467549,"median":-5.225482,"eighty":-1.988482,"marketCap":370034239},{"date":"2026-01-02","current":-5.616652,"twenty":-10.432657,"median":-5.250562,"eighty":-1.988482,"marketCap":333556100},{"date":"2026-01-09","current":-5.640545,"twenty":-10.418119,"median":-5.238277,"eighty":-1.992636,"marketCap":334975047},{"date":"2026-01-16","current":-7.282885,"twenty":-10.370143,"median":-5.311221,"eighty":-1.993674,"marketCap":432508676},{"date":"2026-01-23","current":-7.76882,"twenty":-10.358512,"median":-5.340862,"eighty":-1.996789,"marketCap":461366940},{"date":"2026-01-30","current":-8.980584,"twenty":-10.345428,"median":-5.356212,"eighty":-2.000423,"marketCap":533329955},{"date":"2026-02-06","current":-8.906771,"twenty":-10.297451,"median":-5.376869,"eighty":-2.009249,"marketCap":528946421},{"date":"2026-02-13","current":-9.152815,"twenty":-10.253836,"median":-5.386426,"eighty":-2.014441,"marketCap":543558201},{"date":"2026-02-20","current":-9.841736,"twenty":-10.233483,"median":-5.400438,"eighty":-2.020671,"marketCap":584471184},{"date":"2026-02-27","current":-9.706412,"twenty":-10.211675,"median":-5.415031,"eighty":-2.032093,"marketCap":576434705},{"date":"2026-03-06","current":-8.494648,"twenty":-10.131715,"median":-5.429659,"eighty":-2.035208,"marketCap":504471690},{"date":"2026-03-13","current":-8.627788,"twenty":-10.022678,"median":-5.439635,"eighty":-2.037285,"marketCap":517477458},{"date":"2026-03-20","current":-7.538421,"twenty":-10.003778,"median":-5.449385,"eighty":-2.042477,"marketCap":452139395},{"date":"2026-03-27","current":-8.497064,"twenty":-9.968886,"median":-5.459248,"eighty":-2.051822,"marketCap":509636891},{"date":"2026-04-02","current":-8.372565,"twenty":-9.928179,"median":-5.466715,"eighty":-2.065321,"marketCap":502169684},{"date":"2026-04-10","current":-7.986617,"twenty":-9.906238,"median":-5.479061,"eighty":-2.081935,"marketCap":479021341},{"date":"2026-04-17","current":-8.27919,"twenty":-9.836054,"median":-5.512918,"eighty":-2.084012,"marketCap":496569278},{"date":"2026-04-24","current":-7.731394,"twenty":-9.810397,"median":-5.553616,"eighty":-2.100626,"marketCap":463713567},{"date":"2026-05-01","current":-7.980392,"twenty":-9.782709,"median":-5.593479,"eighty":-2.134892,"marketCap":478647981},{"date":"2026-05-08","current":-9.346147,"twenty":-9.716345,"median":-5.597332,"eighty":-2.142161,"marketCap":546226206},{"date":"2026-05-15","current":-9.090076,"twenty":-9.706412,"median":-5.616855,"eighty":-2.169158,"marketCap":531260417},{"date":"2026-05-22","current":-9.192428,"twenty":-9.705988,"median":-5.636308,"eighty":-2.233537,"marketCap":537242237},{"date":"2026-05-29","current":-8.51435,"twenty":-9.70429,"median":-5.640545,"eighty":-2.258458,"marketCap":497612677},{"date":"2026-06-05","current":-7.893845,"twenty":-9.687959,"median":-5.659308,"eighty":-2.268842,"marketCap":461347892},{"date":"2026-06-12","current":-7.586791,"twenty":-9.667944,"median":-5.675619,"eighty":-2.28961,"marketCap":443402431},{"date":"2026-06-18","current":-7.7787,"twenty":-9.662129,"median":-5.714931,"eighty":-2.297916,"marketCap":454618344},{"date":"2026-06-26","current":-8.546335,"twenty":-9.628373,"median":-5.735345,"eighty":-2.299993,"marketCap":499481996},{"date":"2026-07-02","current":-9.748963,"twenty":-9.663583,"median":-5.762064,"eighty":-2.315568,"marketCap":569768385},{"date":"2026-07-10","current":-9.883299,"twenty":-9.694491,"median":-5.794595,"eighty":-2.329935,"marketCap":577619524},{"date":"2026-07-17","current":-8.962137,"twenty":-9.694491,"median":-5.82665,"eighty":-2.336264,"marketCap":523783141},{"date":"2026-07-24","current":-9.192428,"twenty":-9.67595,"median":-5.858705,"eighty":-2.342386,"marketCap":537242237}],"updateTime":1785096881476},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTNM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652428842","title":"Companies Like Contineum Therapeutics (NASDAQ:CTNM) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2652428842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652428842?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:37","pubTimestamp":1784284678,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Contineum...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ctnm/contineum-therapeutics/news/companies-like-contineum-therapeutics-nasdaqctnm-are-in-a-po-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ctnm/contineum-therapeutics/news/companies-like-contineum-therapeutics-nasdaqctnm-are-in-a-po-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NDX","QQQJ","TECS","QQQE","NQmain","FTEC","QQQ","QYLG","MNQmain","TQQQ","ONEQ","SQQQ","QDTE","BK4007","CTNM","TQQY","QQQA","QID","JEPQ","NVIW.SI","QQQY",".IXIC","IYW","PSQ","QQQM","GPIQ","QLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651425401","title":"Contineum Therapeutics Updates Strategy, Highlights PIPE-791 Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2651425401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651425401?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:07","pubTimestamp":1783976840,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics, Inc. Class A ( ($CTNM) ) has issued an announcement. On July 13, 2026, Contineum Therapeutics updated its corporate present...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-updates-strategy-highlights-pipe-791-leadership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-updates-strategy-highlights-pipe-791-leadership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIPE","BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650130593","title":"Contineum Therapeutics CSO Daniel S. Lorrain Disposes of USD 16,640 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650130593","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650130593?lang=en_us&edition=fundamental","pubTime":"2026-07-11 05:21","pubTimestamp":1783718512,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics CSO Daniel S. Lorrain disposes of USD 16,640 in common sharesContineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 1,040 Class A common shares at USD 16 on July","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL7LNhpK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CSO Daniel S. Lorrain Disposes of USD 16,640 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650391165","title":"Contineum Therapeutics CEO Carmine N. Stengone Disposes of 2,500 Shares for $40,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2650391165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650391165?lang=en_us&edition=fundamental","pubTime":"2026-07-09 06:49","pubTimestamp":1783550995,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics CEO Carmine N. Stengone disposes of 2,500 shares for $40,000Contineum Therapeutics CEO and President Carmine N. Stengone sold 2,500 Class A common shares at USD 16 on July 8, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLtSTLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CEO Carmine N. Stengone Disposes of 2,500 Shares for $40,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648636616","title":"Contineum Therapeutics CSO Daniel S. Lorrain Disposes of USD 556,791 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636616","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636616?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:47","pubTimestamp":1783028871,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics CSO Daniel S. Lorrain disposes of USD 556,791 common sharesContineum Therapeutics CSO Daniel S. Lorrain cut his direct stake to 135,202 Class A shares in transactions on June 30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL3BhwX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CSO Daniel S. Lorrain Disposes of USD 556,791 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648152239","title":"Contineum Therapeutics CEO Carmine Stengone Sells 10,000 Common Shares for $160,080","url":"https://stock-news.laohu8.com/highlight/detail?id=2648152239","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648152239?lang=en_us&edition=fundamental","pubTime":"2026-07-02 07:04","pubTimestamp":1782947093,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics CEO Carmine Stengone sells 10,000 common shares for $160,080Contineum Therapeutics CEO and President Carmine N. Stengone sold 10,000 Class A common shares at USD 16.01 on June 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDLZY3Ph:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CEO Carmine Stengone Sells 10,000 Common Shares for $160,080","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564678","title":"Contineum publishes manuscript on PIPE-791 in Journal of Medicinal Chemistry","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564678?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:10","pubTimestamp":1782850248,"startTime":"0","endTime":"0","summary":"Contineum (CTNM) Therapeutics announced the publication of a manuscript describing the discovery and characterization of PIPE-791 in the Journal of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-publishes-manuscript-on-pipe-791-in-journal-of-medicinal-chemistry-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-publishes-manuscript-on-pipe-791-in-journal-of-medicinal-chemistry-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIPE","CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648561018","title":"Contineum Launches Global Phase 2 Trial of Pipe-791 in Idiopathic Pulmonary Fibrosis Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2648561018","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648561018?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:06","pubTimestamp":1782849967,"startTime":"0","endTime":"0","summary":"Contineum launches global Phase 2 trial of PIPE-791 in idiopathic pulmonary fibrosis patientsContineum Therapeutics highlighted PIPE-791, an oral LPAR1 antagonist now in a global Phase 2 trial in idio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL5qjJWj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646398069","title":"Contineum Stockholders Hold 2026 Virtual Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646398069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646398069?lang=en_us&edition=fundamental","pubTime":"2026-06-27 05:19","pubTimestamp":1782508760,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics, Inc. Class A ( ($CTNM) ) has provided an update. On June 26, 2026, Contineum Therapeutics, Inc. held its 2026 Annual Meetin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/contineum-stockholders-hold-2026-virtual-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/contineum-stockholders-hold-2026-virtual-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646398580","title":"Contineum Therapeutics Shareholders Elect Class II Directors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646398580","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646398580?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:52","pubTimestamp":1782507142,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics shareholders elect Class II directors at annual meetingContineum Therapeutics held its annual shareholder meeting on June 26, 2026.Shareholders selected three Class II directors","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL9b002g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640967052","title":"Contineum Therapeutics CSO Daniel S. Lorrain disposes of 4,170 common shares for $54,866.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2640967052","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640967052?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:09","pubTimestamp":1780351761,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 4,170 Class A common shares on June 1, 2026.He also reported 10,110 shares held indirectly by spouse.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbLWNZl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CSO Daniel S. Lorrain disposes of 4,170 common shares for $54,866.19","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640643089","title":"Contineum Therapeutics to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640643089","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640643089?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:05","pubTimestamp":1780344334,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics will present at the 2026 Goldman Sachs Global Healthcare Conference on June 9 at 1:20 p.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL6lyJ90:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0345770308.USD","LU0345770993.USD","LU2471134952.CNY","LU1894683264.USD","LU0742534661.SGD","LU0868494708.USD","LU1804176565.USD","LU2471134796.USD","LU1868837300.USD","LU2750360641.GBP","LU0096364046.USD","LU0048573561.USD","LU1791807156.HKD","BK4585","LU2750360997.AUD","LU2471134879.HKD","BK4533","LU2237438978.USD","CTNM","LU0106831901.USD","IE0034235188.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0251142724.SGD","LU2237443622.USD","LU2237443895.HKD","LU2237443978.SGD","BK4007","IE0004086264.USD","IE00B19Z3581.USD","LU1868836591.USD","LU1868836757.USD","BK4552","BK4516","LU1868836914.USD","GSX","BK4588","LU2237443549.SGD","LU2471134523.USD","LU2237443382.USD","LU0868494617.USD","IE00B19Z3B42.SGD","LU2237443465.HKD","LU0061475181.USD","LU1868837136.USD","LU0942090050.USD","LU0251131958.USD","BK4127","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037617","title":"Contineum Therapeutics grants 51,000-share inducement stock option to new employee","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037617?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:05","pubTimestamp":1778875523,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics granted non-qualified stock option for 51,000 shares of Class A common stock to one new non-executive employee on May 14, 2026.Exercise price set at closing price of Class A common stock on grant date.Vesting spans four years, with 25% vesting on one-year anniversary of vesting commencement date, remaining portion vesting monthly over next 36 months, subject to continued service.Option carries 10-year term under 2026 Employment Inducement Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL2Nnhz6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744984","title":"Contineum Therapeutics Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744984","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744984?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:56","pubTimestamp":1778777760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 12:56 ET (16:56 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744119","title":"Contineum price target raised to $16 from $14 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744119?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:50","pubTimestamp":1778777447,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Contineum (CTNM) to $16 from $14 and keeps an Equal Weight rating on the shares. Published first o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-price-target-raised-to-16-from-14-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-price-target-raised-to-16-from-14-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0267386448.USD","LU1064131342.USD","LU0158827948.USD","LU1989772840.SGD","LU0557290698.USD","BK4516","LU2028103732.USD","BK4007","LU1791710400.SGD","LU1732799900.SGD","LU0971096721.USD","LU0795875169.SGD","LU1074936037.SGD","LU1791710582.SGD","BK4585","BK4588","IE00BKVL7J92.USD","BK4534","LU0006306889.USD","LU2357305700.SGD","LU1363072403.SGD","LU0098860793.USD","LU1548497426.USD","LU2089284900.SGD","LU2271345857.HKD","LU2023251221.USD","LU0912757837.SGD","LU1244550577.SGD","LU0882574139.USD","LU1732800096.USD","LU0234570918.USD","LU1720051017.SGD","BK4127","LU2111349929.HKD","BK4504","LU2264538146.SGD","LU0225283273.USD","LU0528227936.USD","LU0106831901.USD","LU2133065610.SGD","LU1989772923.USD","LU0158827781.USD","IE00BZ1G4Q59.USD","BK4581","LU0320765646.SGD","LU1720051108.HKD","LU1988902786.USD","LU2089283258.USD","CTNM","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783716","title":"Morgan Stanley Raises Price Target on Contineum Therapeutics to $16 From $14, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783716","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635783716?lang=en_us&edition=fundamental","pubTime":"2026-05-14 18:50","pubTimestamp":1778755853,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics (CTNM) has an average rating of buy and mean price target of $22.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247524","title":"Contineum Therapeutics to present at RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247524?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616333,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics scheduled to present at 2026 RBC Capital Markets Global Healthcare Conference on May 19, 2026.Management fireside chat set for 3:35 p.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL40yFrB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634463232","title":"Contineum presents PIPE-791 pulmonary fibrosis data at ATS 2026 conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2634463232","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634463232?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:06","pubTimestamp":1778529994,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics flagged two upcoming scientific poster presentations on lead investigational candidate PIPE-791 at ATS 2026 in Orlando, scheduled for May 15-20, 2026; results will be presented in the future.One poster is set to compare PIPE-791 with a rival LPA1 antagonist, focusing on differences in lung exposure and vascular effects, positioning the program against a key competitor in pulmonary fibrosis research.A second poster is slated to show preclinical evidence that blocking LPA1 with PIPE-791 can reduce cell death in lab-based lung epithelial models, supporting the drug’s proposed protective effect in fibrotic disease biology.Both posters are scheduled for May 18, 2026, during a pulmonary fibrosis session, keeping near-term investor focus on translational data rather than clinical readouts.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLc3WXC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634332475","title":"Stifel Nicolaus Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634332475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634332475?lang=en_us&edition=fundamental","pubTime":"2026-05-11 10:39","pubTimestamp":1778467161,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Contineum Therapeutics, Inc. Class A on May 8 and set a price target of $28.00. The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-contineum-therapeutics-inc-class-a-ctnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-contineum-therapeutics-inc-class-a-ctnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4127","BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633924402","title":"Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924402","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924402?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:48","pubTimestamp":1778014131,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics (NASDAQ:CTNM) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.51) by 23.53 percent. This is a 37.1 percent increase over losses of $(0.62) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52306237/contineum-therapeutics-q1-eps-0-39-beats-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}